Clinical Trials
All Clinical Trials - Page 8 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07292519Phase 2Not Yet Recruiting
Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)
Tirzepatide
- NCT07040592Phase 2Recruiting
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
Semaglutide
- NCT07401992Phase 4Recruiting
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
Semaglutide
- NCT07299084Phase 1Active Not Recruiting
A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus
Tirzepatide
- NCT07253285Phase 3Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Semaglutide
- NCT07172867Phase 2Withdrawn
A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM
Semaglutide
- NCT07111247Phase 4Recruiting
Insights in Endocervical Mucus Secretion
Gonadorelin
- NCT07423247Phase 4Recruiting
Tirzepatide (Spartina) in Obese Kidney Transplant Recipients
Tirzepatide
- NCT07640139N/AEnrolling By Invitation
Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes
Tirzepatide
- NCT07103395Phase 2Recruiting
A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer
Thymosin-Alpha-1
- NCT07102056N/ANot Yet Recruiting
18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
Octreotide
- NCT07364175N/ARecruiting
A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults
Tirzepatide
- NCT07373834N/ARecruiting
Tirzepatide and Muscle Outcomes in Obesity
Tirzepatide
- NCT07297589Phase 3Recruiting
Epicardial Cardiac Fat-CT (EPIC-CT)
Semaglutide
- NCT07295223Phase 3Recruiting
Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)
Semaglutide
- NCT07280754N/ANot Yet Recruiting
Evaluation of 25(OH)D3 and LL-37 Levels in Periimplant Sulcus Fluid
Ll-37
- NCT07319975N/ANot Yet Recruiting
Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity
Tirzepatide
- NCT07313813Phase 1Completed
A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT07255209Phase 3Recruiting
A Study of IBI362 in Chinese Adolescents With Obesity or Overweight
Mazdutide
- NCT07285902Phase 3Active Not Recruiting
A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity
Semaglutide
- NCT07225686Phase 3Active Not Recruiting
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
Maridebart-Cafraglutide
- NCT07058155Phase 4Recruiting
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
Tirzepatide
- NCT07282041Phase 2/Phase 3Recruiting
Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis
Dulaglutide
- NCT07338214Phase 1Completed
Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations
Petrelintide
- NCT07277439Phase 2Recruiting
Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma
Thymosin-Alpha-1
- NCT07285629EARLY_Phase 1Completed
Safety and Efficacy of Klotho and Follistatin Gene Therapy
Follistatin
- NCT07313761Phase 1Completed
A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations
Maridebart-Cafraglutide
- NCT07307235Phase 4Recruiting
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
Lixisenatide
- NCT07276763N/ANot Yet Recruiting
Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention
Semaglutide
- NCT07326111Phase 4Recruiting
A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese
Tirzepatide
- NCT07224438Phase 2Recruiting
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea
Kisspeptin
- NCT07229170N/ARecruiting
Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients
Tirzepatide
- NCT07251556Phase 4Not Yet Recruiting
GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis
Semaglutide
- NCT07302802N/ARecruiting
Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice
Semaglutide
- NCT07271251Phase 3Completed
A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes
Semaglutide
- NCT07241390Phase 3Recruiting
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Orforglipron
- NCT06692673Phase 1/Phase 2Recruiting
Linaclotide for Colonoscopy Bowel Prep
Linaclotide
- NCT07189624N/ANot Yet Recruiting
Effect of Acute Endurance Exercise on the Production of FGF21 and Follistatin in Patients With Hepatocellular Carcinoma
Follistatin
- NCT07017270Phase 4Recruiting
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
Semaglutide
- NCT07275424Phase 2Recruiting
Study of Healthy Aging and Physical Function With Elamipretide
Elamipretide
- NCT06930625Phase 3Recruiting
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
Octreotide
- NCT07226765Phase 3Active Not Recruiting
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
Maridebart-Cafraglutide
- NCT07247084Phase 4Recruiting
A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
Tirzepatide
- NCT07087054Phase 3Active Not Recruiting
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Octreotide
- NCT07232719Phase 3Active Not Recruiting
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
Retatrutide
- NCT07871799Phase 2Completed
ELITE: Deep Profiling and Algorithmic Polytherapy to Map Individual Response in Healthy Aging
Semaglutide
- NCT07207148N/ARecruiting
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
Semaglutide
- NCT07834398Phase 3Completed
Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes
Tirzepatide
- NCT06935838Phase 2Completed
Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
Tirzepatide
- NCT07262762N/ACompleted
Spartina® (Tirzepatide) Effectiveness and Safety Evaluation
Tirzepatide